Purpose:
To promote initiatives (outside regulatory and reimbursement) which impact on industry development and sustainability and healthcare policy.
Objectives:
- Develop policy positions and engage with stakeholders on the following:
- Digital healthcare agenda including cybersecurity, the electronic patient record, mobile healthcare and registries.
- Supply chain issues, including traceability of medical devices, and regularly engaged with GS1 Australia.
- MTP Connect initiatives, R&D, clinical trials and commercialisation.
- Industry input into NSW Knowledge Hun projects to support the MedTech sector.
- Industry input into export initiatives and issues.
- Monitor the implementation of the $30 million grant for SMEs under the MTAA‐Government Agreement.
MTAA Secretary: Merrilyn Clancy, Senior Policy Officer
Member Name | Company |
Daniel Kildea (Chair) | Johnson & Johnson |
Ross Lane | Cook Medical |
Matthew Malone | Stryker |
Paul Davies | Abbott |
Damon Mogridge | Smith+Nephew |
Jane Crowe | Roche Diabetes Care Australia |
Simon Williamson | Edwards Lifesciences |
Rebecca Cortiula | Varian Medical Systems |
Kate King | Medtronic |
Michael Reynolds | Biotronik |
Kirk Kikirekov | Prospitalia h-trak |
George Sidis | IDE Group |
Geethu Roshan Verghese | Boston Scientific |
Naeema Mohamed | Zimmer Biomet |
Tansy Michael | Fresenius Medical Care |
Meeting dates for 2021:
- Monday, 1 February
- Thursday, 18 March
- Tuesday, 18 May
- Thursday, 22 July
- Wednesday, 15 September
- Monday, 8 November
